Search
for

    Sort by

    Research

    180-210 / 1000+ results
      Lichen Planopilaris: A Rare Inflammatory Cicatricial Alopecia

      research Lichen planopilaris

      April 2012 in “Informa Healthcare eBooks”
      Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.
      Wound Healing and Hair

      research 13. Wound Healing & Hair

      July 2003 in “Journal of Cutaneous Medicine and Surgery”
      Certain drugs can cause lupus, stopping these drugs is the main treatment. NB-UVB phototherapy clears psoriasis faster when applied three times a week. Monoclonal antibodies and oral pimecrolimus are effective in treating psoriasis. Smoking and drinking are linked to psoriasis in men. No direct link between low iron and hair loss was found. Vaccines are effective against genital herpes and human papillomavirus type 16.
      Immunology

      research 9. Immunology

      July 2003 in “Journal of Cutaneous Medicine and Surgery”
      Blood pressure drugs can cause skin lupus, early treatment is key for baby herpes and diabetic foot ulcers, a certain vaccine works against genital herpes and HPV in women, more frequent light therapy helps psoriasis, smoking and drinking can worsen psoriasis, a cream clears up a type of skin cancer, and low iron levels don't cause chronic hair loss.
      Pathology

      research 8. Pathology

      July 2003 in “Journal of Cutaneous Medicine and Surgery”
      Various skin conditions can be treated effectively with different methods, such as discontinuing certain drugs, using specific vaccines, applying creams, and changing lifestyle habits like smoking and drinking.
      HIV, Fungal, and Infectious Diseases

      research 5. HIV, Fungal and Infectious Diseases

      July 2003 in “Journal of Cutaneous Medicine and Surgery”
      The document concludes that various treatments for skin conditions are effective, but some require further research, and certain factors like gender and lifestyle can influence disease outcomes.
      Phototherapy, Photomedicine, and Pigmentary Disorders

      research 6. Phototherapy, Photomedicine, and Pigmentary Disorders

      July 2003 in “Journal of Cutaneous Medicine and Surgery”
      Stopping certain drugs can improve skin conditions, arsenicosis affects over half of a Bangladeshi village, males are more vulnerable, and certain treatments are effective for warts, acne, and psoriasis. Smoking and drinking are linked to psoriasis in men, a cream helps with a type of skin cancer, and low iron levels don't directly cause chronic hair loss in women.
      Bullous/Mucous Membrane

      research 4. Bullous/Mucous Membrane

      July 2003 in “Journal of Cutaneous Medicine and Surgery”
      High blood pressure drugs often cause skin lupus, stopping the drug usually helps. A vaccine helps prevent genital herpes and HPV-16. More frequent light therapy clears psoriasis faster. No link was found between low iron and chronic hair loss.
      Psoriasis, Acne, and Disorders of Keratinization

      research 11. Psoriasis/Acne and Disorders of Keratinization

      July 2003 in “Journal of Cutaneous Medicine and Surgery”
      Treating psoriasis with UVB light three times a week is faster than twice a week, and certain medications and lifestyle factors affect psoriasis treatment outcomes.
      Pediatric Dermatology

      research 3. Pediatric Dermatology

      July 2003 in “Journal of Cutaneous Medicine and Surgery”
      Skin problems are common in Bangladesh due to arsenic, prompt treatment of diabetic foot ulcers is crucial, maternal transmission causes most neonatal herpes, treatments for pediatric vasculitis are effective, the chickenpox vaccine works, more frequent UVB therapy helps psoriasis, certain jobs increase hand dermatitis risk, monoclonal antibodies treat psoriasis well, lifestyle affects psoriasis, alefacept improves psoriasis, imiquimod cream partially clears basal cell carcinoma, and iron may not help chronic hair loss.
      Medical Practice: Therapy and Adverse Reactions

      research 1. Medical Practice; Therapy; Adverse Reactions

      July 2003 in “Journal of Cutaneous Medicine and Surgery”
      Blood pressure drugs can cause skin lupus, but it improves after stopping the drug. The glycoprotein D vaccine works against genital herpes in some women, and the HPV-16 vaccine reduces HPV-16 infection and related diseases. More frequent light therapy clears psoriasis faster. A cream called imiquimod effectively treats a type of skin cancer. Iron supplements don't necessarily help with chronic hair loss in women.
      Cancer

      research 12. Cancer

      July 2003 in “Journal of Cutaneous Medicine and Surgery”
      Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.
      GLP-1 and Aesthetics: Ozempic Face, Skin Laxity, and Recovery

      research GLP-1 e Estética: Ozempic Face, Flacidez e Recuperação

      April 2026 in “Open MIND”
      This review article discusses the aesthetic impacts of GLP-1 medications like Ozempic (semaglutide), including "Ozempic Face," skin sagging, and loss of lean mass, and explores potential recovery methods such as biostimulators, HIFU, endolaser, and PRP.
      The Browning of White Adipose Tissue: Some Burning Issues

      research The Browning of White Adipose Tissue: Some Burning Issues

      437 citations , August 2014 in “Cell metabolism”
      This perspective suggests that browning agents may not directly enhance UCP1 expression in white adipose tissue but instead induce browning through increased heat loss, prompting thermogenesis to compensate.
      Potassium Channel Openers: Pharmacological and Clinical Aspects

      research Potassium channel openers: pharmacological and clinical aspects

      119 citations , October 1992 in “Fundamental & Clinical Pharmacology”
      This review discusses the pharmacological properties and therapeutic potential of K+ channel opening compounds, noting their prospective use in treating cardiovascular and respiratory conditions, but reports no new results.
      Androgen Receptors And Their Biology

      research Androgen receptors and their biology

      66 citations , January 2001 in “Vitamins and hormones”
      This chapter reviews the role of androgen receptors in mediating the actions of androgens in specific tissues and provides no new experimental findings.
      5α-Reduced Glucocorticoids: A Story of Natural Selection

      research 5α-Reduced glucocorticoids: a story of natural selection

      46 citations , September 2011 in “Journal of Endocrinology”
      This study suggests that 5α-reduced glucocorticoids may have anti-inflammatory potential and could serve as biomarkers for liver inflammation in metabolic disease, with implications for drug development.
      Experimental and Clinical Pharmacology of Ziziphus Jujuba Mills

      research Experimental and Clinical Pharmacology ofZiziphus jujubaMills

      31 citations , January 2017 in “Phytotherapy Research”
      This review reports on the traditional and ethnopharmacological uses of Ziziphus jujuba Mills, noting its increasing global popularity for treating various ailments, but highlights that its acceptance into the European Pharmacopoeia remains unresolved due to scientific and regulatory challenges.
      Androgen Antagonists in Androgen Target Tissues

      research Androgen antagonists in androgen target tissues

      27 citations , January 1984 in “Pharmacology & Therapeutics”
      This review discusses androgen manipulation strategies for conditions like benign prostatic hyperplasia and prostatic carcinoma but reports no new clinical results.
      Gilles De La Tourette Syndrome – A Treatable Condition?

      research Gilles de la Tourette syndrome – A treatable condition?

      24 citations , July 2016 in “Revue Neurologique”
      This review discusses treatment options for tics in Gilles de la Tourette syndrome, highlighting existing therapies and potential future advancements, but reports no new clinical findings.